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Abstract 
Hedgehog (Hh) is one of the most important signalling pathways. Together with the Wnt, TGF-ß/BMP and 
Notch pathways, it is involved in both embryonic development and adult tissue homeostasis. This is because 
Hh plays a central role in the proliferative control and differentiation of both embryonic stem cells and adult 
stem cells. In this way, an alteration in the Hh pathway, either by misexpression of components of that 
pathway or by changes in the expression of other cellular components that interfere with the Hh signalling 
system, may trigger the development of several types of cancer. This occurs because normal stem cells or 
their intermediaries toward differentiated mature cells are not part of the normal proliferative/differentiation 
balance and begin to expand without control, triggering the generation of the so-called cancer stem cells. In 
this review, we will focus on the molecular aspects and the role of Hh signalling in normal tissues and in 
tumour development. 
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Introduction 
An important molecular mechanism that provides cell differentiation is signal transduction. 
The signal transduction pathways ensure the reception of the concentration gradients of 
morphogens and their transformation into the differentiated state of cells within tissues and organs. 
Hence it may be assumed that at the molecular level the key molecular rearrangements may be 
related to changes in genes that participate in signal transduction pathways. 
 
The Hedgehog (Hh) cascade, its sensors, switches and routers have been amply described and 
studied [1]. It is involved in diverse morphogenetic processes. A set of proteins accomplishing 
versatile functions can be distin-guished in the Hh signal cascade. These include the Hh 
morphogen, the Ptc and Smo cell receptors, the Cos2, Pka, Slmb, Su(Fu) and Fu proteins that 
make up the high-molecular-weight complex transducing the Hh signal within the cell nucleus, 
and the Ci transcription factor. It is known how these proteins interact in the functioning Hh-
cascade and the interactions can be described as a gene network. A computer-based description has 
been deposited in the Gene Net database [2]. 
  
Evolutionary history 
Hh signal transduction has startling parallels with Wnt signalling, despite the different 
structures of the ligands and the largely distinct components that are dedicated to the separate 
pathways.  
 
As both pathways are found throughout the animal kingdom, a common ancestral pathway (or 
at least components that contributed to both pathways) must have been present in the earliest 
metazoans. 
 
The structure of the Hh molecule itself is very similar to that of zinc hydrolases and other 
enzymes, including bacterial ones. This similarly has fuelled speculation that the Hh signalling 
system is derived from an ancient metabolic pathway [3]. There are further interesting parallels 
between bacterial processes and signalling in animals. The inner bacterial membrane contains 
several translocators with an overall 12-transmembrane topology. Some of these translocators 
serve as efflux pumps to clear toxic drugs from the cell. These pumps contain multiple subunits 
including a 12-transmembrane molecule of the resistance-nodulation-cell division (Rnd) family, a 
proton-driven molecular transporter. The overall organisation of the Rnd proteins is similar to that 
of Ptc/Disp and there is conservation of some essential amino acids between these molecules [4]. 
Ptc may control the translocation of small molecules over membranes in mammalian cells [4]. 
Another class of translocators in the bacterial membrane belongs to the ABC transporter family, 
ATP-driven translocators. These molecules also have 12 transmembrane domains, but their 
topology and sequence appears to be different from the Rnd/Ptc family.  
 
However, the function of these Abc transporters is reminiscent of Disp: they translocate lipid-
modified proteins over the inner membrane into the periplasmic space. Moreover, many bacterial 
lipoproteins carry palmitate as their lipid, covalently linked to a cysteine at the N terminus of the 
protein. Among the functions of bacterial lipoproteins is cell-to-cell communication, as 
exemplified by the Tgl protein in Myxococcus. Hence, a signalling system based on lipid-modified 
proteins and specific membrane translocators is ancient, and may have been the founder of the 
Wnt and Hh signalling systems.  
Structural features 
The Hh proteins are destined for secretion. Because molecules that are secreted from cells are 
commonly glycosylated but not, as far as is known, acylated, the discovery that Wnt and Hh 
proteins carry covalently attached palmitates [5] came as a surprise (Fig. 1). In the case of Hh, 
palmitoylation is one of two lipid modifications, the other one being cholesterol. The Hh protein is 
made as a precursor molecule, consisting of a C-terminal protease domain and an N-terminal 
signalling unit, and undergoes a number of unusual modifications during its synthesis. The N 
terminus of Hh becomes modified by the fatty acid palmitate, on a conserved cysteine residue that 
is exposed at the very N-terminal end of the protein after its signal sequence has been removed. 
The palmitoyl group is attached through an amide to the NH2 group of the cysteine, but it is 
thought that the initial link between palmitate and the cysteine is a thioesther to the sulphydryl 
group, after which the palmitate is transferred to the NH2 terminus [6].  
 
The processing of Hh is unusual in a number of ways: Hh is made initially as a precursor 
molecule that consists of a C-terminal protease domain and an N-terminal signalling unit. The C-
terminal protease of Hh cleaves the precursor in an autocatalytic manner to release the active 
signalling domain of Hh called HhNp. During this cleavage, the C terminus of HhNp becomes 
covalently modified by a cholesterol molecule [7]. Various forms of Hh have been engineered that 
lack the autocatalytic cleavage site and are not therefore cholesterol-modified. These variants are 
called HhN; the mammalian forms of HhN appear not only to lack cholesterol but are also much 
less efficiently palmitoylated [6]. Assuming that the relationship between cholesterol modification 
and palmitoylation is general and also pertains to Drosophila, this should be considered in 
interpreting the relative contributions of the cholesterol and palmitate modifications to Hh activity 
in vivo and in different genetic backgrounds.  
 
 
 
Fig. 1. The Hh protein showing the approximate positions of cysteine 
residues. Hh is palmitoylated through an amide on the N-terminal 
cysteine. The two other cysteines in Hh are not disulphide linked and 
have free sulphydryl groups 
Function 
Transport and release of Hedgehog 
Lipid attachment is a common modification of cytoplasmic proteins and is important for the 
membrane targeting of intracellular signalling molecules. However, as far as is known, it is rare in 
proteins that operate outside cells. It has also been reported that Hh protein can act on cells away 
from their source, as concentration-dependent, long-range morphogenetic signals. The release of 
Hh from cells requires a dedicated transport molecule: a protein called Dispatched (Disp). Initially 
found in Drosophila but functionally conserved in mammals, Disp is a multiple-pass, 
transmembrane protein. In the absence of Disp, Hh is not secreted from cells and is unable to 
signal to neighbouring cells. 
 
Interestingly, non-cholesterol modified HhN is not de-pendent on Disp; it is secreted and is 
fully active, suggesting that the primary function of Disp is to transport cholesterol-modified Hh 
[8]. However, as mentioned above, it should be kept in mind that HhN also lacks palmitate [6]; it 
therefore remains possible that Disp is specifically needed for the release of palmitoylated Hh 
from cells. It is not clear how the palmitate influences Hh transport from one cell to another. 
Variants of Hh that lack the palmitoylation site are secreted from cells, perhaps more efficiently 
than wild-type Hh is [6]. The same is true for Hh protein in the absence of rasp [9]; however, the 
non-palmitoylated Hh protein is not functional. 
 
The palmitate on Hh is attached to a cysteine, but through an amide at the N terminus, which 
leaves the sulphydryl group free. Thus, the lack of palmitate on Hh (in the rasp mutant) does not 
change the overall number of free sulphydryl groups. In fact, none of the three cysteines in Hh are 
involved in disulphide formation.  
 
Evidence has been presented for a freely diffusible form of Sonic Hh (Shh) that is cholesterol 
modified and multimeric [10].  
 
Much work in this area remains to be done, but as answering these questions is central to our 
understanding of developmental mechanisms in general, there will no doubt be significant interest 
in further experimental tests. 
  
Reception of Hedgehog signals 
Cells employ multiple receptors to receive instructions from Hh signals, in complex and little 
understood configurations (Fig. 2). Remarkably, the Frizzled (Fz) receptors for Wnts are related to 
the Smoothened (Smo) protein that is necessary for Hh signalling. Both receptors have seven 
transmembrane domains and a long N-terminal extension called a cysteine-rich domain (CRD). As 
a group, these molecules are more closely related to each other than they are to the other families 
of serpentine receptors, of which there are many.  
 
 
 
Fig. 2. Basic structure of mammalian Hh signalling pathway. Positive regulators are shown in blue boxes 
and negative regulators in red boxes. Abbreviations for the proteins used throughout the text are given in 
parentheses. Only the core, most extensively studied proteins in the pathway are shown 
Although Fz and Smo are related to each other, it should be stressed that the actual 
mechanisms of activation of Fz and Smo are fundamentally different. Smo is not thought to 
interact with an extracellular ligand, whereas Wnt proteins bind directly to the CRD of Fz [11]. 
The way in which Hh engages with its receptor has been subject to debate, but a consensus has 
emerged in which Hh ligands, Sonic, Indian and Desert Hh in vertebrates and Hh in Drosophila, 
bind to Patched (Ptc) (Fig. 2), a 12-pass transmembrane protein. As a consequence of this 
interaction, Smo is activated, or to be more precise, is released from an inhibitory activity that is 
exerted by Ptc when Ptc is not engaged by a ligand. In other words, the negative interaction 
between Ptc and Smo is relieved by binding of Hh to Ptc, which turns Ptc activity off. Inhibition of 
Smo by Ptc may not be by direct binding, but rather by a catalytic activity of Ptc [4].  
 
As Smo can be both activated and inhibited by small molecules, it has been suggested that Ptc 
might act as the transporter of an endogenous small compound that interacts with Smo [12]. Smo 
can be activated to a constitutive, i.e., Ptc-independent, state by specific point mutations found in 
tumours [12] and it is thought that these mutant forms of Smo are refractory to inhibition by small 
molecules.  
 
In mammals a protein called megalin may control the endocytic uptake of the Hh protein by 
acting as a direct binding partner [13]. Moreover, mouse embryos lacking megalin are 
phenotypically similar to Hh mutants. Megalin is an LDL receptor-related protein (it is also called 
Lrp2), and is therefore related to Lrp5 and Lrp6, the Wnt interacting members of the family. 
  
The Hedgehog signalling pathways 
The Hh signalling pathway influences the transcription of many target genes, which vary 
between tissues, cell types and phyla. It participates in the development of numerous tissues and 
organs. One dramatic effect of reduced Hh signalling in human embryos is cyclopia (the formation 
of only one eye), which is a form of holoprosencephaly. In adults, Hh signalling directs the 
formation or the persistence of certain stem- and precursor-cell populations. Increased Hh 
signalling in some organs can lead to distinct types of cancer (skin, cerebellum, muscle, digestive 
tract, pancreas or prostate). Aspects of Hh biology that have been recently reviewed include its 
numerous roles in development, disease and cancer; its unique mode of signal transduction; and 
connections with evolutionarily apparently older proteins that provide clues about the evolutionary 
origins of the Hh signalling pathway.  
 
Hh signals are received, transduced and interpreted using cellular machinery that has been 
largely conserved during the divergent evolution of insects and mammals. Newly identified 
components of Hh signal transduction and the relationships between these components will be the 
focus of this review. 
Hedgehog signalling in vertebrates 
Hh signalling in vertebrates shares many features with that in Drosophila melanogaster, 
although clear distinctions have emerged. First, mammalian gene families take the place of single 
genes in D. melanogaster. There are three Hh genes in mammals, sonic, Indian and desert 
hedgehog (Shh, Ihh and Dhh); two ptc genes (Ptc1 and Ptc2); and three ci homologues (Gli1, Gli2 
and Gli3).  
 
The three Hh genes are expressed in different tissues and at different stages of development, 
and might also have different biological activities. The expression and function of Ptc1 is similar 
to that of D. melanogaster Ptc (that is, where Hh signals are received), whereas Ptc2 expression is 
more restricted and few phenotypes are associated with its loss [14]. The post-translational 
regulation of Ci and the GLI proteins is similar. Each resides in a cytoplasmic pool. In the absence 
of Hh, each is retained in the cytoplasm by Cos2 (Kif7 in vertebrates) and Sufu to limit 
transcriptional activation [15, 16]. Ci, Gli3, and probably also Gli2, require Pka and an SCF E3 
ubiquitin ligase for processing to a transcriptional repressor. However, each Gli protein also has 
unique roles: GLI3 functions mainly as a transcription-al repressor, Gli2 is mainly a transcriptional 
activator and Gli1 functions only as a transcriptional activator. 
 
The transcription of Gli1 is induced by Hh signals, which creates a positive regulatory loop 
that heightens Hh responses. The most important differences between Drosophila and vertebrate 
Hh pathways centre on Smo, its regulators and its effectors. The sequence of the cytoplasmic tail 
of Smo is highly divergent between vertebrates and Drosophila.  
 
Differences in its phosphorylation and regulation are discussed in more detail below. The 
entire Kif7 protein from zebrafish has some sequence similarity to Cos2, and Kif7 can bind Gli1. 
Like Cos2, Kif7 is required for repression of Shh responses [17], although it might differ from 
Cos2 in the degree to which it is required for full activation of Hh responses. Another kinesin and 
two ciliary proteins (Kif3a and the intraflagellar transport proteins Ift88 and Ift172) also mediate 
Cos2-like functions in vertebrates, participating in both full repression and full activation of Hh 
responses.  
 
Some vertebrate Hh pathway genes have no known orthologues in D. melanogaster; some have 
orthologues, the role of which in Hh signalling has not been explored; and some have known 
orthologues with other functions. 
 
Missing in metastasis (Mim), which is also known as Beg4, is an actin-binding protein that 
potentiates Gli-dependent transcriptional activation.  
  
Because Mim is transcriptionally induced by Shh, it functions as a positive regulator that 
reinforces Hh target gene activation, similar to Gli1. Positive vertebrate regulators of the Hh 
signalling pathway that have no known orthologues in flies include megalin, which belongs to the 
low-density lipoprotein (LDL)-receptor-related family and binds Shh41, and iguana, a zinc-finger 
protein that promotes the nuclear localisation of Gli1 [18]. Negative regulatory factors distinguish 
vertebrate Hh signalling as well: Fkbp8 is a transcription factor that antagonises Shh action in the 
nervous system, whereas Sil is a cytosolic protein that seems to functions downstream of Ptc. 
Rab23 is a regulator of vesicular trafficking and a negative regulator of the Hh response [19].  
 
Shifted (Shf) is a secreted protein and is the Drosophila orthologue of human Wnt inhibitory 
factor (Wif). Shf facilitates Hh signalling by binding Hh and heparan sulphate proteoglycans, 
whereas Wif binds Wnt proteins and facilitates Wnt signalling. 
 
At least some of the apparent differences between phyla are the result of the functional 
convergence of non-homologous genes and proteins. The mammalian membrane glycoprotein Hh-
interacting protein (Hip) and Drosophila Pxb have no sequence similarity, but they might fulfil the 
same function. Each is a transcriptional target of Hh and each participates in a negative-feedback 
loop that attenuates Hh responses (Hip through direct binding to Shh).  
The Hedgehog response network 
Several rapid changes in protein conformation or modification are elicited by Hh stimulation, 
including increased phosphorylation of Smo, Cos2, Fu and Su(Fu), and de-creased 
phosphorylation of Ci (Fig. 3).  
 
Although phosphorylation of Ci stimulates processing to form CiR, the residues targeted and 
the functional roles of phosphorylation of other pathway components are largely undefined. These 
changes in phosphorylation, nevertheless, may be functionally important, because they are 
regulated by Ptc and Smo and are triggered by Hh stimulation. 
 
With these phosphorylation events we can surmise that pathway activation begins within 
minutes after Hh stimulation. This kinetic provides constraints in considering the physical 
mechanisms underlying pathway activation. This cellular state, in which Smo is kept inactive, 
must dissipate rapidly upon Hh-mediated inactivation of Ptc. Changes in the subcellular 
distribution of this proposed modulator upon Hh-mediated loss of Ptc function thus should be con-
sistent with the kinetics of pathway induction.  
 
Similarly, critical events proposed to activate Smo, such as change in conformation, subcellular 
localisation, phosphorylation or dimerisation must occur on a sufficiently rapid time scale to be 
consistent with the kinetics of path-way activation.  
One of the primary functions of Smo upon activation would be the inhibition of Su(Fu) activity 
through the activation of Fu. It is tempting to speculate that Su(fu) is inactivated by 
phosphorylation and that this results from Fu activation. However, only a small fraction of Su(Fu) 
associ-ated with the Cos2-Fu-Ci complex is phosphorylated upon Hh stimulation, suggesting that 
phosphorylation may result from a transient interaction between Su(Fu) and the Cos2-Fu-Ci 
complex. Mammalian Su(Fu) is capable of interact-ing with Gli proteins bound to DNA and also 
interacts with chromatin-modulating factors, suggesting that Su(Fu) also could affect 
transcriptional activity by recruiting chromatin-modulating factors to the DNA sites of Gli protein 
binding.  
  
 
 
 
Fig. 3. Hh signalling pathway in Drosophila. In the absence of secreted Hh proteins, the 
Ptch receptor acts by constitutively inhibiting Smo. The Ci155 transcription factor 
forms a multiprotein complex with Cos2, Fu and SuFu, and is sequentially 
phosphorylated by PKA, GSK3 and CKi protein kinases. Phosphorylated Ci155 is 
recognised by the Slimb/β-TrCP component of the E3 ubiquitin ligase, ubiquitinated 
and targeted for degradation by the proteasome. Ci75 degraded form can translocate to 
the nucleus, acting as a transcriptional repressor. In the presence of Hh signalling, the 
repressor activity of the Ptch receptor is inhibited, and Smo is activated. Activated Smo 
blocks the phosphorylation of Ci155 by recruiting Cos2 to the cell membrane and 
promoting the disorganisation of the Ci phosphorylation complex. Ci155 can then 
translocate to the nucleus to activate gene transcription 
Hedgehog as a concentration-dependent signal 
In some tissues, including the wing of Drosophila, Hh functions as a morphogen, with different 
amounts of signal causing the recipient cells to adopt distinct fates. In Drosophila, the wing 
primordium, which is in the centre of the wing imaginal disc, is an epithelial sheet. Hh protein is 
secreted by posterior wing imaginal disc cells whereas Ptc is produced only by anterior cells. 
Anterior cells respond to Hh signals by activating the transcription of target genes that control 
wing growth and patterning. The overlapping (nested) pattern of target gene expression indicates 
that Hh responses are concentration dependent, a supposition that has been supported by 
manipulation of Hh concentrations and Ptc receptor affinities [20]. Induction of the target gene ptc 
requires intermediate or high concentrations of Hh, whereas the target gene decapentaplegic (dpp) 
is induced by low concentrations of Hh. This differential sensitivity is not the result of a different 
affinity or number of Ci binding sites in the respective promoters, but instead reflects differential 
responses to CiR versus CiA.  
 
Hh signalling stimulates the production of both antago-nists and activators, which establishes 
feedback loops that control the strength and duration of the response to the signal. The ptc gene is 
always activated by the Hh signal, so ptc transcription is a reliable indication of Hh signal 
reception by cells in Drosophila and vertebrates. Ptc opposes Hh action by inhibiting Smo and by 
binding to Hh and transporting to the lysosome for degradation, just as the induction of HIP 
production can bind and inactivate SHh. So, Hh triggers a negative-feedback loop in which the 
accumulation of Ptc and HIP attenuates the effect of the ongoing Hh signal. The feedback system 
ensures that Hh signalling is stable and reproducible. Any accidental reduction in the amount of 
Hh will be compensated for by reduced amounts of its antagonist proteins, whereas any increase 
will be balanced by higher induction of antagonists. 
 
The lag between the induction of target genes by Hh and the increase in amounts of antagonist 
proteins might be an important timing mechanism for regulating the persistence of Hh signalling. 
The inducible activators Gli1 and Mim/Beg4 can counteract the effects of Ptc and Hip, at least in 
tissues where both an activator and an inhibitor are induced. However, in Drosophila, the Gli1 
orthologue, ci, is not transcriptionally induced by the Hh signal and nothing has been reported so 
far about the function of the Drosophila MIM/BEG4 orthologue. 
 
Some target genes are activated by only the highest concentrations of Hh (Fig. 4), some are 
activated by both intermediate and high concentrations of Hh, and some are repressed only in the 
absence of Hh. In each case, elimination of the transcriptional effector (Ci, or Gli2 and Gli3) 
generates tissue with cell types that resemble neither dorsal nor ventral tissue in the case of the 
neural tube and neither border nor far-anterior cells in the case of the wing. 
 
Moreover, these phenotypes are recapitulated by loss of the cytoskeletal-association proteins 
(Cos2 or Kif3a/Ift) [21]. These observations illustrate that there is a fundamental similarity 
between Hh signalling in vertebrates and invertebrates. 
 
 
 
 
Fig. 4. Three states for the Hh pathway, for Cubitus interruptus and for Hh target genes. 
In the nucleus, the repressor form of Cubitus interruptus (CiR) competes with the 
activator form (CiA) for access to the promoter elements of Hh target genes. When Hh 
is absent, CiR predominates and transcription is blocked. When concentrations of Hh 
are high, CiA predominates and transcription is activated. When Hh concentrations are 
low, neither CiR nor CiA reaches the nucleus in significant quantities. Alternatively, 
similar amounts of CiR and CiA reach the nucleus. In either case, low Hh 
concentrations allow target genes to respond to transcriptional regulation by other 
factors. Complex I contains Fused (Fu), Costal-2 (Cos2) and Ci, whereas Complex II 
contains Suppressor of Fused (Sufu) and Ci 
 
  
Hedgehog in development and cancer 
The Hh pathway plays a central role during embryo development to give rise to the distinct 
structures and organs integrated in a normal individual. This is achieved through the key action of 
Hh signalling on fate and proliferative capacities of distinct sets of embryonic stem cells. 
Moreover, in adult individuals Hh also plays important roles control-ling the normal self-renewal 
and maintenance of tissues as it is able to regulate the proliferative activity of stem cells and their 
differentiation toward mature cells through pro-genitor or transient-amplifying cells. For instance, 
in nor-mal adult tissues, expression of several components of the Hh signal transduction 
machinery has been detected, such as Ptc and Gli in sets of stem cells of the central nervous 
system and gut epithelium [22–26]. Indeed, increasing evidence indicates that the Hh pathway can 
be transiently reactivated by tissue damage to stimulate tissue repair, including peripheral nerve 
regeneration [27–29]. In this way, it has been shown that Hh signalling can regulate cell 
proliferation through the activation of the cell cycle regulatory proteins cyclin D and E [30]. 
Although less clear, the control of cell differentiation by Hh signalling might occur through the 
induction of protein secretion, including neurotrophic and angiogenic factors [29].  
 
On the other hand, Hh signalling plays an important role in the morphogenesis of the intestine. 
Here, the ligands Sonic Hedgehog (Shh) and Indian Hedgehog (Ihh) are localised in the gut 
epithelial cells where paracrine communication is established with mesenchymal cells, which 
express the Patched-1 and Patched-2 receptors, as well as the effectors of Hh signalling, Gli1, Gli2 
and Gli3.  
 
Blocking Hh signals through the pain inhibitor Hhip (Hedgehog interacting protein) markedly 
compromises the crypt-villus architecture and leads to a complete absence of villi in an often 
pseudostratified and hyperproliferating epithelium. A milder phenotype is observed when Hh 
signalling is suppressed by the injection of an anti-Hh antibody, and is characterised by the 
presence of ectopic proliferation and abnormally branched villi. The general conclusion is that Hh 
signals from the epithelium to the mesenchyme are required for epithelial remodelling as well as 
for restraining proliferation to the intervillus regions, where the proteins Shh and Ihh become 
concentrated as development proceeds [31]. 
 
A similar profile in Hh signalling is observed during prostate development and its regrowth 
after surgical resection, where a cross-talk between proliferative epithelium and mesenchyme has 
been established. Despite some contradictory data, it is generally accepted that Hh signalling (both 
autocrine, on the same cell, and paracrine, on the surrounding mesenchymal cells) in epithelial 
cells located in the tips of prostate branches is associated with the production of BMP cytokines 
from the mesenchyme, which gives rise to an antiproliferative signal that controls branching 
morphogenesis. Thus, the expression of Hh ligands is mainly restricted to the developing 
epithelium whereas the expression of Hh receptors and effectors is restricted to the mesenchyme 
neighbour of proliferative branched epithelium (for review, see [32]). 
 
In agreement with a key role in the regulation of cell proliferation and differentiation, several 
reports have indicated that aberrant activation of Hh signalling can promote cancer. 
 
The first link between Hh signalling and cancer was the demonstration that Gorlin syndrome is 
the result of a PTCH1 mutation [33, 34]. Gorlin syndrome is characterised by the development of 
numerous basal cell carcinomas and the predisposition to other tumours, especially 
medulloblastoma and rhabdomyosarcoma. After that, it was shown that a large proportion of 
sporadic BCCs involve hyperactivation of Hh signalling after overexpression of GLI1 and PTCH1 
[35–38]. Similarly, more than one third of human medulloblastomas are associated with abnormal 
Hh signalling linked to Ptch1 and SuFu mutations [39]. These observations have been largely 
corroborated in mouse models. Overexpression of Shh, Gli1, Gli2 or constitutively active Smo in 
the skin induces the formation of BBC-like lesions [40–42]. In the same way, mice heterozygous 
for a Ptch1 mutation, a mouse model of Gorlin syndrome, have a higher incidence of spontaneous 
medulloblastoma and are more susceptible to UV-induced BBC [43].  
  
On the other hand, in mice expressing the hedgehog inhibitor Hhip, Wnt target genes that are 
normally restricted to the crypt compartment, such as Cdx1, Cd44 and EphB2, showed expression 
throughout the entire villus epithelium. These results indicate that the Hh signal negatively 
regulates Wnt signalling under normal conditions and that Hh alteration may be associated with a 
Wnt pathway malfunction, which may be behind the start of colorectal cancer. Indeed, in human 
adenomas of patients with familial adenomatous polyposis (FAP), the expression of IHH is lost in 
the neo-plastic tissue, where Wnt signalling is constitutively active due to a mutation of APC. 
Therefore, the role of Hh restricting Wnt signalling to the crypts seems to be lost in neoplastic 
conditions, which leads to aberrant Wnt activation [31]. 
 
As a whole, these results highlight the importance of Hh signalling during carcinogenesis. The 
association of Hh signalling and cancer has prompted the development of pharmacological Hh 
antagonists for the treatment of BBC, medulloblastoma and other solid tumours in preclinical 
models. The most widely used Hh antagonist is cyclopamine, a natural SMOH inhibitor derived 
from corn lilies [44]. Cell-based pharmacological screenings have identi-fied additional synthetic 
inhibitors of SMOH, such as the aminoproline Cur-61414 (Curis) [44]. Both types of inhibitors 
can efficiently block the Hh pathway in vitro and can prevent the formation of BCC-like lesions in 
mouse models [44]. Cyclopamine can also significantly reduce the growth rate of mouse 
medulloblastoma cells both in culture and in mouse allograft models [44]. These results indicate 
that inhibition of Hh signalling can block tumour growth and stimulate tumour regression without 
side effects in normal adjacent tissues, suggesting that this therapeutic modality has a potential 
clinical application. 
Conclusions  
Our knowledge on the molecular basis of the signal transduction mechanisms involved in Hh 
signalling has been greatly enriched in recent years. This accumulated mass of data has permitted 
precise delineation of the role of this signalling pathway during embryo development from 
Drosophila to mammals. Also, it has become clear that the role of Hh signalling mechanisms in 
the adult organism is considerably more important than previously supposed. The discovery that 
this signalling pathway is implicated in the regulation of adult stem function has stressed the 
importance that homeostatic mechanisms that operate during development have for the 
maintenance of adult tissues. Similarly, but not surprisingly, it has been shown that the Hh 
signalling mechanism, which is essential in the regulation of stem cell proliferation and 
differentiation from the embryo to the adult organism, is also causally implicated in the process of 
carcinogenesis.  
 
The realisation that Hh signalling is equally important for tumour formation has fostered 
efforts in the develop-ment of pharmacological inhibitors of Hh signalling with potential clinical 
applications. Preclinical results, in cellular in vitro or mouse models, indicate that natural or 
synthetic inhibitors of the Hh signalling pathway can prevent the formation and even promote the 
regression of tumours. However, although promising, the development of a potential clinical 
application of these drugs in human cancer patients is still in the very early stages and will require 
further efforts in basic and translational biomedicine investigation in the next years.  
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